Showing results (231-240 of 245) with videos related to
Sort By:
Pageof 25
Frontiers in Immunology|January 30, 2023
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosisC Caruso, L Laterza, C R Settanni, et al.The British Journal of Dermatology|October 5, 2021
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trialM Goebeler, Z Bata-Csörgő, C De Simone, et al.Environmental Research|August 16, 2000
Evaluation of genotoxic and cytotoxic properties of pesticides employed in Italian agricultural practicesA De Marco, R De Salvia, S Polani, et al.Diabetologia|June 30, 2005
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouseF Calcinaro, S Dionisi, M Marinaro, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2015
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology groupP Quaglino, P Fava, M Caproni, et al.European Review for Medical and Pharmacological Sciences|December 11, 2014
Investigating psoriasis awareness among patients in Italy: validation of a questionnaireF Bardazzi, P Amerio, G Amoruso, et al.Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 9, 2017
Consensus on the management of patients with psoriatic arthritis in a dermatology settingP Gisondi, G Altomare, F Ayala, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2017
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasisP Gisondi, G Altomare, F Ayala, et al.International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.Pageof 25